HealthCare Global Enterprises Partners with Accenture to Advance Cancer Research Utilizing Cutting-Edge AI
Click to start listening
Bengaluru, Dec 3 (NationPress) HealthCare Global Enterprises (HCG) has announced a strategic alliance with Accenture aimed at expediting cancer research and patient care through the implementation of advanced AI technologies, which encompass generative AI and deep learning.
The partnership will leverage Accenture’s extensive global knowledge and skills in data and AI, including AI/ML, generative AI, and quantum computing, while integrating deep clinical insights from HCG in the field of oncology to facilitate early detection and treatment of various cancer types.
Accenture will employ state-of-the-art technologies, including image analysis software, informatics, and innovative algorithms to scrutinize data from cancer patients and investigate molecular alterations. This initiative aims to propel research for the identification and development of new drug targets.
“In today’s landscape, optimizing cancer care requires technology-driven advancements in research and education, particularly to ensure smooth, error-free data collection and processing. AI has become essential for accurate, personalized medical innovations,” stated Dr. B. S. Ajaikumar, Executive Chairman of HealthCare Global Enterprises.
“Accenture’s profound expertise in technology and analytics, utilizing AI modeling, will support us in enhancing our research focused on developing patient-centric therapies with enduring results,” Ajaikumar further commented.
This pioneering program in South Asia will initiate research on molecular signatures for the prognosis and therapeutic response in cases of lung adenocarcinoma and head and neck cancers.
Subsequently, it will expand to include additional cancer types to elucidate their development, symptoms, and origins, leading to new treatment algorithms for precision medicine and improving the quality of therapy and care.
The research will exemplify data-driven clinical practice. By utilizing AI, generative AI, cloud computing, machine learning, and quantum computing, it will enhance the overall efficiency of patient care.
“Next-generation computing, particularly generative AI, combined with comprehensive biological and clinical knowledge, can significantly influence cancer research and treatment, meeting patient needs while benefiting the global healthcare sector,” remarked Senthil Ramani, Global Lead of Data and AI at Accenture.
